JPML Centralizes Lipitor Diabetes Suits In SC

By Brian Mahoney (February 18, 2014, 7:33 PM EST) -- The Judicial Panel on Multidistrict Litigation on Tuesday agreed to centralize in South Carolina federal court 56 lawsuits alleging Pfizer Inc.'s blockbuster cholesterol drug Lipitor causes Type 2 diabetes, reversing a prior decision declining consolidation.

The JPML said in an order that a spate of related filings against Pfizer had caused it to reconsider its July order declining to centralize the suits. The panel said that plaintiffs' counsel has increased significantly since then and that informal coordination and cooperation are no longer practicable.

"Upon re-evaluation, we find that a number of factors now tip the balance in favor of centralization," the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!